Literature DB >> 142654

Nicotinamide and streptozotocin diabetes in the rat. Factors influencing the effectiveness of the protection.

P Masiello, E Bergamini.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 142654     DOI: 10.1007/bf01922358

Source DB:  PubMed          Journal:  Experientia        ISSN: 0014-4754


× No keyword cloud information.
  11 in total

1.  Pyridine nucleotide depletion in pancreatic islets associated with streptozotocin-induced diabetes.

Authors:  C K Ho; S A Hashim
Journal:  Diabetes       Date:  1972-07       Impact factor: 9.461

2.  Studies on the ability of compounds to block the diabetogenic activity of streptozotocin.

Authors:  W E Dulin; B M Wyse
Journal:  Diabetes       Date:  1969-07       Impact factor: 9.461

3.  Reversal of streptozotocin diabetes with nicotinamide.

Authors:  W E Dulin; B M Wyse
Journal:  Proc Soc Exp Biol Med       Date:  1969-03

4.  The use of nicotinamide to modify the toxicity of streptozotocin diabetes without loss of antitumor activity.

Authors:  P S Schein; D A Cooney; M L Vernon
Journal:  Cancer Res       Date:  1967-12       Impact factor: 12.701

5.  On the relative efficacy of nicotinamide and nicotinic acid as precursors of nicotinamide adenine dinucleotide.

Authors:  B Petrack; P Greengard; H Kalinsky
Journal:  J Biol Chem       Date:  1966-05-25       Impact factor: 5.157

6.  Streptozotocin diabetes: time course of irreversible B-cell damage; further observations on prevention by nicotinamide.

Authors:  W Stauffacher; I Burr; A Gutzeit; D Beaven; J Veleminsky; A E Renold
Journal:  Proc Soc Exp Biol Med       Date:  1970-01

7.  Age-dependent changes in the sensitivity of the rat to a diabetogenic agent (streptozotocin).

Authors:  P Masiello; A De Paoli; E Bergamini
Journal:  Endocrinology       Date:  1975-03       Impact factor: 4.736

8.  Diabetogenic action of streptozotocin: relationship of dose to metabolic response.

Authors:  A Junod; A E Lambert; W Stauffacher; A E Renold
Journal:  J Clin Invest       Date:  1969-11       Impact factor: 14.808

9.  6-Amnionicotinamide (6-AN) as a diabetogenic agent. In vitro and in vivo studies in the rat.

Authors:  H P Ammon; J Steinke
Journal:  Diabetes       Date:  1972-03       Impact factor: 9.461

10.  The role of the pentose phosphate shunt in glucose induced insulin release: in vitro studies with 6-aminonicotinamide, methylene blue, NAD + , NADH, NADP + , NADPH and nicotinamide on isolated pancreatic rat islets.

Authors:  H P Ammon; T N Patel; J Steinke
Journal:  Biochim Biophys Acta       Date:  1973-02-28
View more
  2 in total

1.  Development of a type II diabetic mellitus animal model using Micropig®.

Authors:  Myeong-Seop Lee; Ki-Duk Song; Hee-Jun Yang; Chester D Solis; Soo-Hyeon Kim; Woon-Kyu Lee
Journal:  Lab Anim Res       Date:  2012-09-26

2.  Mild gestational hyperglycemia in rat induces fetal overgrowth and modulates placental growth factors and nutrient transporters expression.

Authors:  Ouma Cisse; Isabelle Fajardy; Anne Dickes-Coopman; Emmanuelle Moitrot; Valérie Montel; Sylvie Deloof; Jean Rousseaux; Didier Vieau; Christine Laborie
Journal:  PLoS One       Date:  2013-05-14       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.